BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18204434)

  • 1. Genetic alterations in combined neuroendocrine neoplasms of the lung.
    D'Adda T; Pelosi G; Lagrasta C; Azzoni C; Bottarelli L; Pizzi S; Troisi I; Rindi G; Bordi C
    Mod Pathol; 2008 Apr; 21(4):414-22. PubMed ID: 18204434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of a combined lung small cell carcinoma and large cell neuroendocrine carcinoma with adenocarcinoma.
    Fellegara G; D'Adda T; Pilato FP; Froio E; Ampollini L; Rusca M; Rindi G
    Virchows Arch; 2008 Jul; 453(1):107-15. PubMed ID: 18551311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.
    Buys TP; Aviel-Ronen S; Waddell TK; Lam WL; Tsao MS
    J Thorac Oncol; 2009 Feb; 4(2):227-39. PubMed ID: 19179901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
    Rekhtman N; Pietanza CM; Sabari J; Montecalvo J; Wang H; Habeeb O; Kadota K; Adusumilli P; Rudin CM; Ladanyi M; Travis WD; Joubert P
    Mod Pathol; 2018 Jan; 31(1):111-121. PubMed ID: 28884744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma: a morphological, immunohistochemical, and molecular analysis.
    Hiroshima K; Iyoda A; Shida T; Shibuya K; Iizasa T; Kishi H; Tanizawa T; Fujisawa T; Nakatani Y
    Mod Pathol; 2006 Oct; 19(10):1358-68. PubMed ID: 16862075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
    Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
    Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade neuroendocrine carcinoma of the lung shows increased thymidylate synthase expression compared to other histotypes.
    Ibe T; Shimizu K; Nakano T; Kakegawa S; Kamiyoshihara M; Nakajima T; Kaira K; Takeyoshi I
    J Surg Oncol; 2010 Jul; 102(1):11-7. PubMed ID: 20578072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.
    Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH
    Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
    Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
    Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung.
    Miyoshi T; Umemura S; Matsumura Y; Mimaki S; Tada S; Makinoshima H; Ishii G; Udagawa H; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Aokage K; Hishida T; Yoshida J; Nagai K; Goto K; Tsuboi M; Tsuchihara K
    Clin Cancer Res; 2017 Feb; 23(3):757-765. PubMed ID: 27507618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
    Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
    J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
    Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.